AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in treatment-induced leukemia after breast cancer

Haematologica. 2001 Feb;86(2):212-3.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Acute Disease
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / toxicity
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology*
  • Chromosomes, Human, Pair 16
  • Chromosomes, Human, Pair 21
  • Core Binding Factor Alpha 2 Subunit
  • Female
  • Humans
  • Leukemia, Myeloid / chemically induced*
  • Middle Aged
  • Neoplasms, Second Primary / chemically induced*
  • Oncogene Proteins, Fusion / genetics*
  • Transcription Factors / genetics*
  • Translocation, Genetic

Substances

  • AML1-MTG16 protein, human
  • Core Binding Factor Alpha 2 Subunit
  • Oncogene Proteins, Fusion
  • Transcription Factors